IDH1/IDH2 mutations can act by increasing the levels of HIF-1α and the associated transcriptional activity of its target genes, related to the adaptation of cells to low oxygen tension and involved in angiogenesis, invasion, and glucose metabolism, functions that are relevant to tumor growth, progression, and chemotherapy resistance. The gene discussed is IDH1; the disease is neoplasm.